PriceTargets.com logo

NYSE:COO - The Cooper Companies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $444.73
  • Forecasted Upside: 0.43 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$442.84 As of 09/16/2021 03:20 PM ET
▼ -2.19 (-0.49%)

This chart shows the closing price for COO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New The Cooper Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COO

Analyst Price Target is $444.73
▲ +0.43% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for The Cooper Companies in the last 3 months. The average price target is $444.73, with a high forecast of $480.00 and a low forecast of $335.00. The average price target represents a 0.43% upside from the last price of $442.84.

This chart shows the closing price for COO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 11 contributing investment analysts is to buy stock in The Cooper Companies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/18/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/17/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/3/2021Robert W. BairdReiterated RatingHold$423.00High
9/3/2021Stifel NicolausBoost Price TargetBuy$450.00 ➝ $475.00High
9/3/2021CitigroupBoost Price TargetNeutral$400.00 ➝ $453.00High
9/3/2021OppenheimerBoost Price TargetPositive ➝ Outperform$405.00 ➝ $475.00High
9/3/2021KeyCorpBoost Price TargetOverweight$444.00 ➝ $476.00High
8/19/2021Wells Fargo & CompanyBoost Price TargetOverweight$445.00 ➝ $480.00Medium
8/6/2021Piper SandlerBoost Price TargetOverweight$440.00 ➝ $460.00Low
7/16/2021StephensBoost Price TargetOverweight$430.00 ➝ $450.00Low
7/1/2021Stifel NicolausBoost Price TargetBuy$405.00 ➝ $450.00Medium
6/1/2021Piper SandlerBoost Price TargetOverweight$435.00 ➝ $440.00Medium
5/24/2021Jefferies Financial GroupReiterated RatingBuy$450.00Low
4/28/2021KeyCorpBoost Price TargetOverweight$429.00 ➝ $444.00Low
4/23/2021Redburn PartnersInitiated CoverageBuyMedium
3/8/2021KeyCorpBoost Price TargetOverweight$425.00 ➝ $429.00Medium
3/5/2021CitigroupBoost Price TargetNeutral$355.00 ➝ $378.00High
3/5/2021Jefferies Financial GroupBoost Price TargetBuy$425.00 ➝ $435.00High
3/5/2021Raymond JamesBoost Price TargetOutperform$375.00 ➝ $415.00High
3/5/2021Robert W. BairdBoost Price TargetNeutral$351.00 ➝ $384.00High
3/1/2021KeyCorpBoost Price TargetOverweight$425.00 ➝ $429.00Low
2/23/2021KeyCorpBoost Price TargetOverweight$396.00 ➝ $425.00Low
2/11/2021Piper SandlerBoost Price TargetOverweight$370.00 ➝ $435.00Low
1/25/2021Wells Fargo & CompanyBoost Price Target$415.00 ➝ $445.00Medium
1/8/2021KeyCorpBoost Price TargetOverweight$367.00 ➝ $396.00Medium
12/4/2020Smith Barney CitigroupBoost Price Target$330.00 ➝ $335.00Medium
12/4/2020Piper SandlerBoost Price TargetOverweight$351.00 ➝ $370.00High
12/4/2020KeyCorpBoost Price TargetOverweight$349.00 ➝ $367.00High
11/20/2020Wells Fargo & CompanyBoost Price TargetOverweight$360.00 ➝ $380.00Low
9/24/2020OppenheimerReiterated RatingHoldLow
9/17/2020Raymond JamesBoost Price TargetPositive ➝ Outperform$330.00 ➝ $375.00Medium
9/4/2020JPMorgan Chase & Co.Boost Price TargetNeutral$285.00 ➝ $315.00High
9/4/2020OppenheimerBoost Price TargetMarket Perform$330.00 ➝ $340.00High
9/4/2020Raymond JamesReiterated RatingBuyHigh
9/4/2020StephensBoost Price TargetOverweight$325.00 ➝ $365.00High
9/4/2020CitigroupBoost Price TargetNeutral$310.00 ➝ $330.00High
9/4/2020KeyCorpBoost Price TargetPositive ➝ Overweight$330.00 ➝ $349.00High
7/6/2020Robert W. BairdDowngradeOutperform ➝ Neutral$335.00 ➝ $291.00High
6/5/2020OppenheimerInitiated CoverageHold$330.00Low
6/5/2020Raymond JamesLower Price TargetOutperform$340.00 ➝ $330.00High
5/26/2020StephensBoost Price TargetOverweight$300.00 ➝ $325.00High
5/26/2020KeyCorpLower Price TargetOverweight$380.00 ➝ $330.00High
5/21/2020Wells Fargo & CompanyLower Price TargetOverweight$388.00 ➝ $329.00High
4/21/2020Raymond JamesLower Price TargetOutperform$360.00 ➝ $340.00High
4/8/2020Jefferies Financial GroupLower Price TargetBuy$360.00 ➝ $340.00High
3/27/2020CitigroupLower Price TargetNeutral$360.00 ➝ $318.00Medium
3/23/2020StephensLower Price TargetOverweight$375.00 ➝ $300.00Low
3/6/2020Piper SandlerBoost Price Target$344.00 ➝ $351.00High
3/6/2020Stifel NicolausBoost Price TargetBuy$320.00 ➝ $350.00High
3/6/2020Robert W. BairdBoost Price TargetOutperform$345.00 ➝ $357.00High
3/6/2020StephensBoost Price TargetOverweight$340.00 ➝ $375.00High
3/6/2020Raymond JamesBoost Price TargetOutperform$355.00 ➝ $360.00High
3/4/2020CitigroupInitiated CoverageNeutral$360.00High
1/22/2020KeyCorpBoost Price TargetOverweight$351.00 ➝ $380.00Low
1/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$360.00 ➝ $388.00Medium
12/6/2019Piper Jaffray CompaniesReiterated RatingBuy$344.00Low
12/6/2019Robert W. BairdReiterated RatingBuy$345.00Low
12/6/2019Raymond JamesLower Price TargetBuy ➝ In-Line$364.00 ➝ $355.00High
12/4/2019Jefferies Financial GroupLower Price TargetAverage ➝ In-Line$358.00 ➝ $330.00Low
12/3/2019Northcoast ResearchReiterated RatingBuyLow
11/27/2019KeyCorpBoost Price TargetOverweight$348.00 ➝ $351.00Low
10/11/2019KeyCorpLower Price TargetOverweight$351.00 ➝ $348.00Low
8/30/2019Piper Jaffray CompaniesSet Price TargetBuy$360.00Medium
8/30/2019KeyCorpSet Price TargetBuy$351.00Medium
8/26/2019Raymond JamesReiterated RatingBuyLow
8/22/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$314.00 ➝ $351.00Low
8/13/2019Piper Jaffray CompaniesBoost Price TargetOverweight$330.00 ➝ $360.00Medium
8/8/2019Wells Fargo & CompanyBoost Price TargetOutperform$356.00 ➝ $365.00Low
7/2/2019Raymond JamesBoost Price TargetOutperform$325.00 ➝ $364.00High
6/10/2019Wells Fargo & CompanyBoost Price TargetOutperform$325.00 ➝ $356.00Low
6/3/2019Northcoast ResearchReiterated RatingPositive ➝ Buy$331.00 ➝ $340.00Low
3/6/2019Jefferies Financial GroupBoost Price TargetBuy$330.00Low
3/6/2019Wells Fargo & CompanyBoost Price TargetOutperform$305.00 ➝ $325.00Medium
3/6/2019StephensBoost Price TargetOverweight$305.00 ➝ $320.00High
3/6/2019Raymond JamesBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $325.00High
3/6/2019KeyCorpBoost Price TargetOverweight$296.00 ➝ $314.00High
3/6/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$306.00 ➝ $320.00High
3/6/2019Piper Jaffray CompaniesReiterated RatingOverweight$325.00High
2/1/2019StephensUpgradeEqual Weight ➝ Overweight$305.00Low
1/12/2019William BlairReiterated RatingOutperformHigh
1/4/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell$233.00 ➝ $221.00Medium
12/9/2018KeyCorpReiterated RatingBuyHigh
12/7/2018OppenheimerSet Price TargetHold$282.00High
12/7/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$295.00 ➝ $305.00High
12/7/2018Jefferies Financial GroupBoost Price TargetBuy$305.00High
12/7/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$294.00 ➝ $306.00High
12/7/2018KeyCorpLower Price TargetOverweight ➝ Overweight$298.00 ➝ $296.00High
11/12/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $295.00High
9/21/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$270.00 ➝ $300.00Low
8/31/2018OppenheimerSet Price TargetHold$270.00Medium
8/31/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$280.00 ➝ $285.00High
6/8/2018OppenheimerSet Price TargetHold$265.00High
6/5/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$275.00 ➝ $270.00Low
4/4/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$231.00Low
3/29/2018OppenheimerSet Price TargetHold$265.00N/A
3/9/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$277.00 ➝ $280.00Low
3/9/2018OppenheimerSet Price TargetHold$265.00High
3/9/2018StephensReiterated RatingHold$270.00Medium
3/9/2018Jefferies Financial GroupReiterated RatingBuy$285.00Medium
2/9/2018Cleveland ResearchDowngradeBuy ➝ HoldLow
12/8/2017OppenheimerSet Price TargetHold$250.00Medium
12/8/2017Stifel NicolausReiterated RatingBuy ➝ Buy$275.00 ➝ $265.00High
12/4/2017Raymond JamesReiterated RatingBuy$265.00Medium
10/20/2017KeyCorpReiterated RatingHoldN/A
10/16/2017Robert W. BairdSet Price TargetBuy$273.00N/A
10/13/2017BMO Capital MarketsReiterated RatingBuy$272.00N/A
9/12/2017Jefferies Financial GroupReiterated RatingBuy$250.00Low
9/12/2017StephensReiterated RatingEqual Weight$235.00 ➝ $250.00Low
9/12/2017OppenheimerReiterated RatingHold$250.00Medium
9/12/2017Robert W. BairdReiterated RatingBuy$267.00 ➝ $273.00Medium
9/12/2017JPMorgan Chase & Co.Reiterated RatingHold$235.00Medium
9/12/2017Stifel NicolausBoost Price TargetBuy$265.00 ➝ $275.00High
9/3/2017Robert W. BairdReiterated RatingBuy$251.00 ➝ $267.00Medium
9/1/2017BMO Capital MarketsReiterated RatingBuy$272.00N/A
9/1/2017Piper Jaffray CompaniesBoost Price TargetOverweight$265.00 ➝ $280.00High
8/28/2017KeyCorpReiterated RatingHoldLow
8/24/2017Robert W. BairdReiterated RatingBuy$251.00Low
8/22/2017Cleveland ResearchReiterated RatingBuyLow
8/17/2017Jefferies Financial GroupSet Price TargetBuy$250.00Low
7/21/2017KeyCorpReiterated RatingOverweight ➝ Sector WeightMedium
7/19/2017Piper Jaffray CompaniesBoost Price TargetOverweight$265.00Low
7/13/2017BMO Capital MarketsReiterated RatingBuy$255.00Medium
7/6/2017Jefferies Financial GroupReiterated RatingBuy$250.00High
7/6/2017Robert W. BairdBoost Price TargetOutperform$239.00 ➝ $251.00Low
6/29/2017GuggenheimInitiated CoverageNeutralHigh
6/5/2017JPMorgan Chase & Co.Reiterated RatingNeutral$200.00 ➝ $206.00Low
6/5/2017BMO Capital MarketsReiterated RatingOutperform$220.00 ➝ $255.00Low
6/3/2017OppenheimerSet Price TargetHold$225.00Medium
6/3/2017Jefferies Financial GroupReiterated RatingBuy$220.00 ➝ $250.00Medium
6/2/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$220.00 ➝ $231.00High
4/6/2017Piper Jaffray CompaniesReiterated RatingOverweight$220.00Low
3/4/2017OppenheimerSet Price TargetHold$203.00N/A
3/3/2017Jefferies Financial GroupBoost Price TargetBuy$210.00 ➝ $220.00N/A
3/3/2017BMO Capital MarketsReiterated RatingBuyN/A
12/12/2016Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
12/9/2016OppenheimerSet Price TargetHold$188.00N/A
12/9/2016BMO Capital MarketsSet Price TargetBuy$206.00 ➝ $203.00N/A
12/7/2016Jefferies Financial GroupReiterated RatingBuy$210.00N/A
10/1/2016KeyCorpSet Price TargetBuy$221.00N/A
(Data available from 9/16/2016 forward)

News Sentiment Rating

0.38 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 4 very negative mentions
Mentions as of
2/18/2021
  • 0 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2021
  • 0 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/18/2021
  • 2 very positive mentions
  • 25 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
7/18/2021
  • 5 very positive mentions
  • 25 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
8/17/2021
  • 15 very positive mentions
  • 51 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
9/16/2021

Current Sentiment

  • 15 very positive mentions
  • 51 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

The Cooper Companies logo
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, basies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Read More

Today's Range

Now: $442.84
Low: $439.64
High: $444.84

50 Day Range

MA: $427.86
Low: $396.76
High: $455.92

52 Week Range

Now: $442.84
Low: $314.29
High: $463.59

Volume

2,444 shs

Average Volume

270,985 shs

Market Capitalization

$21.83 billion

P/E Ratio

7.55

Dividend Yield

0.01%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of The Cooper Companies?

The following Wall Street analysts have issued research reports on The Cooper Companies in the last twelve months: Citigroup Inc., Jefferies Financial Group Inc., KeyCorp, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Redburn Partners, Robert W. Baird, Smith Barney Citigroup, Stephens, Stifel Nicolaus, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for COO.

What is the current price target for The Cooper Companies?

11 Wall Street analysts have set twelve-month price targets for The Cooper Companies in the last year. Their average twelve-month price target is $444.73, suggesting a possible downside of 0.1%. Wells Fargo & Company has the highest price target set, predicting COO will reach $480.00 in the next twelve months. Smith Barney Citigroup has the lowest price target set, forecasting a price of $335.00 for The Cooper Companies in the next year.
View the latest price targets for COO.

What is the current consensus analyst rating for The Cooper Companies?

The Cooper Companies currently has 2 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe COO will outperform the market and that investors should add to their positions of The Cooper Companies.
View the latest ratings for COO.

What other companies compete with The Cooper Companies?

Other companies that are similar to The Cooper Companies include Align Technology, West Pharmaceutical Services, DENTSPLY SIRONA, STAAR Surgical, Quidel, ICU Medical, Neogen, Merit Medical Systems, Haemonetics, Atrion, Cerus, Meridian Bioscience, OraSure Technologies, Antares Pharma and Anika Therapeutics.

How do I contact The Cooper Companies' investor relations team?

The Cooper Companies' physical mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company's listed phone number is (925) 460-3600 and its investor relations email address is [email protected] The official website for The Cooper Companies is www.coopercos.com.